Funds and ETFs Adimmune Corporation

Equities

4142

TW0004142005

Pharmaceuticals

End-of-day quote Taiwan S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
27.05 TWD 0.00% Intraday chart for Adimmune Corporation -1.10% -18.40%

ETFs positioned on Adimmune Corporation

Name Weight AuM 1st Jan change Investor Rating
0.01% 4 M€ -4.41% -
0.00% 117 M€ +1.11% -
0.00% 34 M€ +2.14% -
ADIMMUNE CORPORATION is a Taiwan-based company principally engaged in the research and development, processing, manufacture and trading of influenza vaccine products and non-flu vaccine products. The Company's products include Japanese encephalitis vaccines, tetanus vaccines, influenza vaccines, H1N1 influenza vaccines and tuberculin. The vaccine products are applied in the prevention of various infectious viruses. The tuberculin is applied in tuberculin purified protein derivative (PPD) test. The Company distributes its products within domestic market and to overseas markets, including other markets in Asia, Europe and Africa.
More about the company
  1. Stock Market
  2. Equities
  3. 4142 Stock
  4. Funds and ETFs Adimmune Corporation